2006 – Southlake First in Canada to Implant New Victory Pacemaker
Newmarket, Ontario, (March 7, 2006) – On February 28, 2006, Southlake’s arrhythmia team was the first to implant one of St. Jude Medical’s new Victory® pacemakers in a patient suffering from atrial fibrillation (AF), the world’s most common cardiac arrhythmia.
The Victory® family of pacemaker devices has recently been available in U.S. and Europe, however the device implant at Southlake represents a first in Canada.
“This next generation pacemaker offers an important combination of features for patients who suffer from atrial fibrillation and the physicians who care for them,” said Dr. Yaariv Khaykin, who led the arrhythmia team through the implant procedure. “Southlake is honoured to have participated in this important milestone.”
The technology of the device is such that it comes already programmed which greatly reduces the amount of time required to set-up the device at the time of implant. It also measures and stores much of the information that physicians need during patient follow-up, eliminating 80% of standard testing that is traditionally done in order to gather this information. According to Dr. Khaykin, these upgrades allow clinicians more time to spend with patients and less time programming their pacemaker.
Victory® pacemakers are the first to utilize Ventricular Intrinsic Preference (VIPTM) technology, which is designed to promote more natural heart function and minimize ventricular pacing. This technology is designed to allow the patient’s own heartbeat to be “in control” the majority of the time.
“There is an accumulating body of evidence to suggest that the traditional method of pacing, which involves electrically stimulating one ventricle at a time may, over time, wear out the heart,” said Dr. Khaykin. “This enhanced technology allows the heart muscle to perform at its best.”
Atrial fibrillation is a condition that results in a very fast, uncontrolled heart rhythm, which is caused when the atria (upper chambers of the heart) quiver instead of beating. Pacemakers are one of the mainstay therapies for individuals who suffer from atrial fibrillation but they are largely used to prevent the heart from beating too slowly.
Southlake is funded to implant 475 pacemakers each year through its comprehensive arrhythmia program.
Southlake’s Cardiac Care Program offers a full scope of advanced-level cardiac services to a population of close to one million people who reside in York Region, Simcoe County and Muskoka.